HCPCS
HCPCS Code Q5121: Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
Reviewed by HealthAssure Clinical TeamUpdated 22 May 2026
What is this code?
HCPCS codes are used to standardize how healthcare services, supplies, equipment, transportation, and certain procedures are documented and billed. Coverage indicator: C.
When is it used?
- Used in procedure coding, claims, and care documentation.
- Coverage code: C
- Pricing indicator: 51
What it does not mean
- The presence of a procedure code does not by itself explain why a service was needed or whether it was appropriate in a specific case.
Where you may see this code
You may see this code on claims, billing records, explanations of benefits, preauthorization paperwork, or procedure documentation.
Coverage-related procedures and services
ICD10 K50.814high
Crohn's disease of both small and large intestine with abscess
Source: CMS coverage guidance
ICD10 K50.813high
Crohn's disease of both small and large intestine with fistula
Source: CMS coverage guidance
ICD10 K50.812high
Crohn's disease of both small and large intestine with intestinal obstruction
Source: CMS coverage guidance
ICD10 K50.818high
Crohn's disease of both small and large intestine with other complication
Source: CMS coverage guidance
ICD10 K50.811high
Crohn's disease of both small and large intestine with rectal bleeding
Source: CMS coverage guidance
ICD10 K50.80high
Crohn's disease of both small and large intestine without complications
Source: CMS coverage guidance
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from HCPCS. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.